111 related articles for article (PubMed ID: 9757563)
1. Synthesis and biological activities of (-)-6-n-octyl-indolactam-V, a new potent analogue of the tumor promoter (-)-indolactam-V.
Nakagawa Y; Irie K; Nakamura Y; Ohigashi H; Hayashi H
Biosci Biotechnol Biochem; 1998 Aug; 62(8):1568-73. PubMed ID: 9757563
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological activities of indolactone-V, the lactone analogue of the tumor promoter (-)-indolactam-V.
Nakagawa Y; Irie K; Nakamura Y; Ohigashi H; Hayashi H
Biosci Biotechnol Biochem; 1997 Aug; 61(8):1415-7. PubMed ID: 9301127
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and PKC isozyme surrogate binding of indothiolactam-V, a new thioamide analogue of tumor promoting indolactam-V.
Nakagawa Y; Irie K; Ohigashi H; Hayashi H; Wender PA
Bioorg Med Chem Lett; 2000 Sep; 10(18):2087-90. PubMed ID: 10999477
[TBL] [Abstract][Full Text] [Related]
4. The amide hydrogen of (-)-indolactam-V and benzolactam-V8's plays a critical role in protein kinase C binding and tumor-promoting activities.
Nakagawa Y; Irie K; Nakamura Y; Ohigashi H
Bioorg Med Chem Lett; 2001 Mar; 11(5):723-8. PubMed ID: 11266178
[TBL] [Abstract][Full Text] [Related]
5. New teleocidin-related metabolites, (-)-7-geranylindolactam V and blastmycetin F, from Streptoverticillium blastmyceticum.
Irie K; Kajiyama S; Okuno S; Kondo M; Koshimizu K; Hayashi H; Arai M; Nishino H; Iwashima A
J Nat Prod; 1994 Mar; 57(3):363-8. PubMed ID: 8201310
[TBL] [Abstract][Full Text] [Related]
6. Structure-activity relationship in the induction of Epstein-Barr virus by teleocidin derivatives.
Irie K; Tokuda H; Hagiwara N; Koshimizu K; Hayashi H; Murao S; Ito Y
Int J Cancer; 1985 Oct; 36(4):485-8. PubMed ID: 2995261
[TBL] [Abstract][Full Text] [Related]
7. Quantitative structure-activity studies on indole alkaloid tumor promoter indolactam congeners.
Irie K; Okuno S; Kajiyama S; Koshimizu K; Nishino H; Iwashima A
Carcinogenesis; 1991 Oct; 12(10):1883-6. PubMed ID: 1934269
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity studies on synthetic analogues (indolactams) of the tumor promoter teleocidin.
Fujiki H; Suganuma M; Nakayasu M; Tahira T; Endo Y; Shudo K; Sugimura T
Gan; 1984 Oct; 75(10):866-70. PubMed ID: 6595181
[TBL] [Abstract][Full Text] [Related]
9. Modular Total Synthesis of Protein Kinase C Activator (-)-Indolactam V.
Haynes-Smith J; Diaz I; Billingsley KL
Org Lett; 2016 May; 18(9):2008-11. PubMed ID: 27074538
[TBL] [Abstract][Full Text] [Related]
10. Pendolmycin, a new tumor promoter of the teleocidin A class on skin of CD-1 mice.
Nishiwaki S; Fujiki H; Yoshizawa S; Suganuma M; Furuya-Suguri H; Okabe S; Nakayasu M; Okabe K; Muratake H; Natsume M
Jpn J Cancer Res; 1991 Jul; 82(7):779-83. PubMed ID: 1908844
[TBL] [Abstract][Full Text] [Related]
11. Effects of synthetic analogues of teleocidin, indolactam-V, on the differentiation of murine pre-adipose cells.
Sato M; Hiragun A; Shudo K
Cancer Lett; 1985 Jan; 25(3):261-9. PubMed ID: 3918784
[TBL] [Abstract][Full Text] [Related]
12. Synthetic analogues (indolactams) of (-)-indolactam-V are new congeners of the teleocidin class of tumor promoters.
Hirota M; Suganuma M; Yoshizawa S; Horiuchi T; Nakayasu M; Hasegawa M; Endo Y; Shudo K; Fujiki H
Jpn J Cancer Res; 1987 Jun; 78(6):577-82. PubMed ID: 3112073
[TBL] [Abstract][Full Text] [Related]
13. Indolactam and benzolactam compounds as new medicinal leads with binding selectivity for C1 domains of protein kinase C isozymes.
Irie K; Nakagawa Y; Ohigashi H
Curr Pharm Des; 2004; 10(12):1371-85. PubMed ID: 15134488
[TBL] [Abstract][Full Text] [Related]
14. Effect of alteration of the heterocyclic nucleus of ILV on its isoform selectivity for PKC. Palladium catalyzed route to benzofuran analogues of ILV.
Kozikowski AP; Ma D; Du L; Lewin NE; Bumberg PM
Farmaco; 1995 Jun; 50(6):425-30. PubMed ID: 7669180
[TBL] [Abstract][Full Text] [Related]
15. Indolactam-V is involved in the CH/pi interaction with Pro-11 of the PKCdelta C1B domain: application for the structural optimization of the PKCdelta ligand.
Nakagawa Y; Irie K; Yanagita RC; Ohigashi H; Tsuda K
J Am Chem Soc; 2005 Apr; 127(16):5746-7. PubMed ID: 15839646
[TBL] [Abstract][Full Text] [Related]
16. Isolation of (-)-14-O-Malonylindolactam-V as a Possible Precursor of (-)-Indolactam-V and (-)-14-O-Acetylindolactam-V from Streptomyces blastmyceticum.
Irie K; Tomimatsu S; Nakagawa Y; Ohigashi H; Hayashi H
Biosci Biotechnol Biochem; 1999; 63(9):1669-70. PubMed ID: 27389654
[TBL] [Abstract][Full Text] [Related]
17. Enzymatic Formation of Indolactam Scaffold by C-N Bond-Forming Cytochrome P450 Oxidases in Teleocidin Biosynthesis.
Morita I; Mori T; Abe I
Chemistry; 2021 Feb; 27(9):2963-2972. PubMed ID: 32996659
[TBL] [Abstract][Full Text] [Related]
18. Structure-activity studies of the indole alkaloid tumor promoter teleocidins.
Irie K; Hagiwara N; Tokuda H; Koshimizu K
Carcinogenesis; 1987 Apr; 8(4):547-52. PubMed ID: 3103947
[TBL] [Abstract][Full Text] [Related]
19. Twist form of teleocidin derivatives is active in in vivo tumor promotion by (-)-benzolactam-V8-310.
Okabe S; Sueoka N; Komori A; Suganuma M; Endo Y; Shudo K; Fujiki H
Biol Pharm Bull; 1998 May; 21(5):465-8. PubMed ID: 9635501
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of (-)-epi-indolactam V by an intramolecular Buchwald-Hartwig C-N coupling cyclization reaction.
Mari M; Bartoccini F; Piersanti G
J Org Chem; 2013 Aug; 78(15):7727-34. PubMed ID: 23845025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
